Akèy › Trombositopeni › Maryland
Etid klinik pou Trombositopeni nan Maryland
3 etid pou Trombositopeni ap chèche patisipan nan sit nan Maryland.
Tèks ofisyèl etid la (Anglè)
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- American Oncology Partners of Maryland, PA, Bethesda
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06722235Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 2
Laj 3 a 99 · Tout sèks · Mizajou Mar 9, 2026 · NCT04304820A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
- Maryland Oncology Hematology - Independent of SCRI/ US Oncology, Columbia
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 12, 2026 · NCT05980806Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.